Nagarro Se NAGARRO N ORD SHS/ DE000A3H2200 /
24/05/2024 17:22:49 | Chg. - | Volume | Bid06:00:04 | Demandez à06:00:04 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
83.10EUR | - | 607 Chiffrre d'affaires: 46,074.05 |
-Bid taille: - | -Ask la taille: - | 1.05 Mrd.EUR | - | 20.03 |
GlobeNewswire
11:39
Correction: Amarna Therapeutics announces formation of Scientific Advisory Board to support advancem...
GlobeNewswire
11:23
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groun...
GlobeNewswire
10:20
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
Newsfile Corp
10:19
Shelf Gains Adaptation Among SMBs and Enterprises, Grows Double Digits in US and Canadian Market
GlobeNewswire
10:00
Castle Ridge announces launch of Multi-Strategy powered by WALLACE AI supercomputer
GlobeNewswire
10:00
Cognitiv Partners With Adform to Offer ContextGPT™ to European Advertisers for the First Time
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page